Reckitt Benckiser has announced plans to sell the E45 skin care brand and related Karo Pharma for 200 200m ($ 267.98m) as the British consumer goods company focuses on higher growth areas.
Durex and Lysol, the company, said the operations generated a total net income of 43 43m last year.
The company has narrowed its portfolio to focus on high-growth categories, such as disinfectants and healthcare products that exploded during the pandemic.
“As we move from a brand-based strategy to a category-based growth strategy, we focus on high-growth categories with brands that we can expand to new places and spaces to support our medium-term development ambitions, such as 4% growth.” 6% in health activities “, said the managing director Lazman Narasimhan.
Source From: Capital